UK regulators use AI and process reforms to reduce clinical trial approvals from 91 to 41 days, speeding up patient access to new medicines and treatments.
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)
Professor Freimut Schliess, Director of Science & Innovation, at the Profil Institut für Stoffwechselforschung GmbH, illustrates how dissipating initial scepticism of digital health technologies makes for a thrilling challenge for regulators, manufacturers and clinical researchers alike.
McLean Hospital’s Clinical and Translational Pain Research Laboratory is one of five institutions splitting a $1.67 million NIH grant - the research will examine any links between the menstrual cycle and the COVID vaccine.
The REACH study found that 97% of women and girls in Uganda, South Africa and Zimbabwe are happy to work with HIV prevention methods - globally, half of all people living with HIV are women.
The team will have results to discuss in April, 2022 - they nurse the hope that this HIV vaccine could stop different geographical strains, after 40 years of no cure.
